Pharmaceutical stock prices will fall 10% or more by Nov 2026

Major pharmaceutical companies (e.g., Pfizer, Merck, Johnson & Johnson) will experience a sustained decline in stock prices due to the heightened risk of price controls and reduced profit margins. Investor sentiment will reflect regulatory uncertainty and potential earnings impact.

Implied probability (Yes)

75%